Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Conference Call February 26, 2024 5:00 PM ET Company Participants Rick Winningham - Chief Executive Officer Aine Miller - Head, Development Rhonda Farnum - Chief Business Officer Aziz Sawaf - Chief Financial Officer Conference Call Participants Douglas Tsao - H.C. Wainwright David Risinger - Leerink Partners Eva Privitera - Cowen Julian Harrison - BTIG Operator Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Bioph ...